Alzheimer's research may have produced a side benefit in the form of a potential treatment for a rare childhood leukemia. Scientists say the inhibition of a key cellular enzyme could lead to safe, effective treatments for both diseases. Clinical trials could begin as early as next year, and the development also may speed research into proving these drugs can fight Alzheimer's.

Full Story:

Related Summaries